Factors influencing nitroxide reduction and cytotoxicity in vitro
Nitroxides have been shown to be effective antioxidants, radiation protectors, and redox-active probes for functional electron paramagnetic resonance (EPR) imaging. More recently, the nitroxide 4-hydroxy-2,2,6,6-tetramethylpiperidinyl-N-oxyl (Tempol) has been shown to exert differential cytotoxicity...
Saved in:
Published in | Antioxidants & redox signaling Vol. 6; no. 3; p. 587 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2004
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Nitroxides have been shown to be effective antioxidants, radiation protectors, and redox-active probes for functional electron paramagnetic resonance (EPR) imaging. More recently, the nitroxide 4-hydroxy-2,2,6,6-tetramethylpiperidinyl-N-oxyl (Tempol) has been shown to exert differential cytotoxicity to tumor compared with normal cell counterparts. Nitroxides are readily reduced in tissues to their respective hydroxylamines, which exhibit less cytotoxicity in vitro and do not provide radiation protection or an EPR-detectable signal for imaging. In order to better understand factors that influence nitroxide reduction, the rate of reduction of Tempol in mouse and human cell lines and in primary cultures of tumor cells was measured using EPR spectroscopy. Additionally, the cytotoxicity of high concentrations of Tempol and the hydroxylamine of Tempol (Tempol-H) was evaluated in wild-type and glucose-6-phosphate dehydrogenase (G6PD)-deficient Chinese hamster ovary cells. The results show that in general Tempol was reduced at a faster rate when cells were under hypoxic compared with aerobic conditions. Neither depletion of intracellular glutathione nor treatment of cells with sodium cyanide influenced Tempol reduction rates. G6PD-deficient cells were found to reduce Tempol at a significantly slower rate than wild-type cells. Likewise, Tempol-induced cytotoxicity was markedly less for G6PD-deficient cells compared with wild-type cells. Tempol-H exhibited no cytotoxicity to either cell type. Tempol-mediated cytotoxicity was enhanced by glutathione depletion and inhibition of 6-phosphogluconate dehydrogenase in wild-type cells, but was unaltered in G6PD-deficient cells. Collectively, the results indicate that while the bioreduction of Tempol can be influenced by a number of factors, the hexose monophosphate shunt appears to be involved in both nitroxide reduction as well as cytotoxicity induced by high levels of exposure to Tempol. |
---|---|
AbstractList | Nitroxides have been shown to be effective antioxidants, radiation protectors, and redox-active probes for functional electron paramagnetic resonance (EPR) imaging. More recently, the nitroxide 4-hydroxy-2,2,6,6-tetramethylpiperidinyl-N-oxyl (Tempol) has been shown to exert differential cytotoxicity to tumor compared with normal cell counterparts. Nitroxides are readily reduced in tissues to their respective hydroxylamines, which exhibit less cytotoxicity in vitro and do not provide radiation protection or an EPR-detectable signal for imaging. In order to better understand factors that influence nitroxide reduction, the rate of reduction of Tempol in mouse and human cell lines and in primary cultures of tumor cells was measured using EPR spectroscopy. Additionally, the cytotoxicity of high concentrations of Tempol and the hydroxylamine of Tempol (Tempol-H) was evaluated in wild-type and glucose-6-phosphate dehydrogenase (G6PD)-deficient Chinese hamster ovary cells. The results show that in general Tempol was reduced at a faster rate when cells were under hypoxic compared with aerobic conditions. Neither depletion of intracellular glutathione nor treatment of cells with sodium cyanide influenced Tempol reduction rates. G6PD-deficient cells were found to reduce Tempol at a significantly slower rate than wild-type cells. Likewise, Tempol-induced cytotoxicity was markedly less for G6PD-deficient cells compared with wild-type cells. Tempol-H exhibited no cytotoxicity to either cell type. Tempol-mediated cytotoxicity was enhanced by glutathione depletion and inhibition of 6-phosphogluconate dehydrogenase in wild-type cells, but was unaltered in G6PD-deficient cells. Collectively, the results indicate that while the bioreduction of Tempol can be influenced by a number of factors, the hexose monophosphate shunt appears to be involved in both nitroxide reduction as well as cytotoxicity induced by high levels of exposure to Tempol. |
Author | Samuni, Ayelet Krishna, Murali C Samuni, Yuval Mitchell, James B Yamada, Kenichi Gamson, Janet Russo, Angelo |
Author_xml | – sequence: 1 givenname: Yuval surname: Samuni fullname: Samuni, Yuval organization: Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA – sequence: 2 givenname: Janet surname: Gamson fullname: Gamson, Janet – sequence: 3 givenname: Ayelet surname: Samuni fullname: Samuni, Ayelet – sequence: 4 givenname: Kenichi surname: Yamada fullname: Yamada, Kenichi – sequence: 5 givenname: Angelo surname: Russo fullname: Russo, Angelo – sequence: 6 givenname: Murali C surname: Krishna fullname: Krishna, Murali C – sequence: 7 givenname: James B surname: Mitchell fullname: Mitchell, James B |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15130285$$D View this record in MEDLINE/PubMed |
BookMark | eNo1T8lOwzAU9KGILvADHJB_IODnJU6OVUUpUiUucK68PCOj1qkSB5G_xxVwGmk2zSzJLHUJCbkD9gCsaR9BccGamkmtRSukkDAjiwtZFVbOyXIYPhljHIBdkzkoEIw3akHWW-Ny1w80pnAcMbmYPmiKue--o0faox9djl2iJnnqptzlIriYpxKgXxffDbkK5jjg7R-uyPv26W2zq_avzy-b9b5yola5slzp2nOJ2mlrrNNBIfrGllGBmbZpQ9GUQitbXg4giBCksApqo2SQwFfk_rf3PNoT-sO5jyfTT4f_L_wHhw1Mng |
CitedBy_id | crossref_primary_10_1080_13102818_2019_1573153 crossref_primary_10_1016_j_freeradbiomed_2008_01_027 crossref_primary_10_1111_j_1476_5381_2011_01527_x crossref_primary_10_1016_j_redox_2015_10_007 crossref_primary_10_3390_pharmaceutics12080772 crossref_primary_10_1158_1535_7163_MCT_09_1207 crossref_primary_10_4161_cbt_10_10_13250 crossref_primary_10_1016_j_freeradbiomed_2005_12_011 crossref_primary_10_1016_j_tetlet_2019_151207 crossref_primary_10_1371_journal_pone_0055868 crossref_primary_10_1016_j_pharmthera_2009_02_002 crossref_primary_10_1007_s11060_010_0387_2 crossref_primary_10_1124_pr_108_000240 crossref_primary_10_3892_ijo_2012_1638 crossref_primary_10_1016_j_freeradbiomed_2011_05_019 crossref_primary_10_1158_0008_5472_CAN_06_0879 crossref_primary_10_1080_10715760400019661 crossref_primary_10_3164_jcbn_21_83 crossref_primary_10_1007_s12013_018_0862_5 crossref_primary_10_1039_D1PY01645H crossref_primary_10_1089_pho_2007_2046 crossref_primary_10_3390_antiox12020402 crossref_primary_10_1016_j_freeradbiomed_2010_11_028 crossref_primary_10_1021_acscentsci_7b00253 crossref_primary_10_1124_jpet_107_127167 crossref_primary_10_1186_s40795_015_0025_7 crossref_primary_10_1042_CBI20090276 crossref_primary_10_1038_ncomms6460 crossref_primary_10_1021_acsabm_9b00855 crossref_primary_10_1211_jpp_60_8_0011 crossref_primary_10_1016_j_ultsonch_2012_01_014 crossref_primary_10_1016_j_ejmech_2018_12_033 crossref_primary_10_3390_ijms151221703 crossref_primary_10_1089_152308604773934332 crossref_primary_10_1016_j_freeradbiomed_2020_05_021 crossref_primary_10_1152_ajpheart_00687_2008 crossref_primary_10_1124_jpet_111_183681 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1089/152308604773934341 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine Chemistry |
ExternalDocumentID | 15130285 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0VX 1-M 23M 34G 39C 4.4 53G 5GY 5RE 6AZ ABBKN ABJNI ACGFS ACPRK ADBBV AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BNQNF CAG CGR COF CS3 CUY CVF EBS ECM EIF EJD F5P IAO IER IHR IM4 ITC MV1 NPM NQHIM O9- P2P RIG RML RMSOB UE5 Z0Y |
ID | FETCH-LOGICAL-c365t-b2576d24e7c7babc7f5eed8b000f0a989f24e55eb492934e13ff43b516a54f412 |
ISSN | 1523-0864 |
IngestDate | Sat Sep 28 07:41:18 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c365t-b2576d24e7c7babc7f5eed8b000f0a989f24e55eb492934e13ff43b516a54f412 |
PMID | 15130285 |
ParticipantIDs | pubmed_primary_15130285 |
PublicationCentury | 2000 |
PublicationDate | 2004-06-01 |
PublicationDateYYYYMMDD | 2004-06-01 |
PublicationDate_xml | – month: 06 year: 2004 text: 2004-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Antioxidants & redox signaling |
PublicationTitleAlternate | Antioxid Redox Signal |
PublicationYear | 2004 |
SSID | ssj0002110 |
Score | 2.0060081 |
Snippet | Nitroxides have been shown to be effective antioxidants, radiation protectors, and redox-active probes for functional electron paramagnetic resonance (EPR)... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 587 |
SubjectTerms | Animals Cell Line Cell Line, Tumor CHO Cells Cricetinae Cyclic N-Oxides - pharmacology Dose-Response Relationship, Drug Electron Spin Resonance Spectroscopy - methods Fibroblasts - metabolism Free Radical Scavengers - pharmacology Glucosephosphate Dehydrogenase - metabolism Glutathione - metabolism Humans Mice Mice, Inbred C3H Nitrogen Oxides - chemistry Oxygen - metabolism Oxygen Consumption Spin Labels Time Factors |
Title | Factors influencing nitroxide reduction and cytotoxicity in vitro |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15130285 |
Volume | 6 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6ugnoRXd8vevAm1XaTtN3jIq6LoCcFPUmSJlhwuyJV1F_vTJo-fOHjUpZMG7qdr5Nv0nkQstePeI-ZSPs6CJXPZEh9AcuUr1IB9B3bIRl0FM_Oo9ElO73iV82nGJtdUsgD9fplXsl_tApjoFfMkv2DZutJYQB-g37hCBqG4690PHTNcjLXaQTdfnhFHybPWYrtUNJH1wgcc9deikkBAoW0O8v3n_C8NjUdYNwjXGgDYxAQWEr0eR8DPMRdtcDhXozAjBJruh-fRB2gcSLGLnnrVORNVnVz9uAFVrh6_FqMRSpcZlCmbrN32w-sCZOqLGaP-uAXsbZJjVrIoS3zyMvF9ZPZDhKseopTwUwBi7FMH6NlRayWHu_HVpFAUijQIv6z9EMp7UrUIZ04QaN4jls7btlGT9gW13X_x2VYwa0dfr4x282pnOyDP2J5ycUiWXAOhTco0bFEpnTeJXNHVR-_Lpk9c-ETy2TgAOO1AOPVgPFqwHgAGK8NGLjAs4BZIZfD44ujke96aPiKRrzwJTqUaY_pWMVSSBUbDqwoQe5nAtFP-gZknGvJgCdTpkNqDKOSh5HgzLCwt0qm80mu14mnkpBqxYVRXLEwljKNRWq0CGScGJ7yDbJWPoib-7JQyk31iDa_lWyR-QZU22TGwJupd4DmFXLXqucN_WtQig |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+influencing+nitroxide+reduction+and+cytotoxicity+in+vitro&rft.jtitle=Antioxidants+%26+redox+signaling&rft.au=Samuni%2C+Yuval&rft.au=Gamson%2C+Janet&rft.au=Samuni%2C+Ayelet&rft.au=Yamada%2C+Kenichi&rft.date=2004-06-01&rft.issn=1523-0864&rft.volume=6&rft.issue=3&rft.spage=587&rft_id=info:doi/10.1089%2F152308604773934341&rft_id=info%3Apmid%2F15130285&rft_id=info%3Apmid%2F15130285&rft.externalDocID=15130285 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1523-0864&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1523-0864&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1523-0864&client=summon |